Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT06744816
Phase
EARLY_PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Peripheral Neuropathy Due to Chemotherapy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Qutenza Patch — DRUG
    Given topical

Study Details

To learn if topical capsaicin can help relieve pain from CIPN and improve gait (the pattern of walking) in patients.

Key Dates

Start date
Dec 11, 2025
Status verified
Dec 2025
Primary completion
Nov 30, 2027
Completion
Nov 30, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment with Qutenza Patch (Topical Capsaicin)
    Up to 4 topical capsaicin patches will be applied on your feet for 30 minutes.

Primary Outcome Measure

Safety and adverse events (AE)s [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Saba Javed, MD
[email protected]
713-792-9530
Saba Javed, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
MD Anderson Cancer Center· Houston, TX

Related Studies